Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOBT | Common Stock | Conversion of derivative security | +2.37M | 2.37M | Nov 9, 2021 | Direct | F1 | |||
transaction | IOBT | Common Stock | Purchase | $4.55M | +325K | +13.74% | $14.00 | 2.69M | Nov 9, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IOBT | Series C Preferred Stock | Conversion of derivative security | $0 | -188K | -100% | $0.00* | 0 | Nov 9, 2021 | Common Stock | 2.37M | Direct | F1 |
HBM Healthcare Investments (Cayman) Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | Upon the closing of the Issuer's initial public offering, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date. |